A contribution of the HIF-1α/VEGF axis to cisplatin-induced antiangiogenesis was additionally reported for lung cancer cell lines containing exon 19 deletions in the epidermal growth factor receptor (EGFR) [13]. The gene discussed is EGFR; the disease is lung carcinoma.